Company: INKT
Filing Date: 2025-04-18
Form Type: PRE 14A
Source: 0000950170-25-055881
Chunk: 22

Company: MiNK Therapeutics, Inc.
Filing Date: 2025-04-18
Form: PRE 14A
Chunk 22
---
 academic and industry partnerships; and • Elevate scientific and investor engagement through high-impact publications, medical congress presentations, and earned media visibility. Ms. Klaskin was not eligible to receive an annual bonus in respect of her service to the Company for fiscal year 2024. Agreements with Our Named Executive Officers Dr. Buell is and, prior to his resignation in November 2024, Dr. van Dijk was, party to an employment agreement with us or one of our subsidiaries that sets, or did set, forth the terms and conditions of his or her employment. The agreements with Drs. Buell and van Dijk were entered into and effective in 2022. The material terms of the agreements are described below. The terms “cause,” “good reason,” and “change in control” referred to below are defined in the respective named executive officer’s agreement. Dr. Buell. We are party to an employment agreement with Dr. Buell that provides for her entitlement to an annual base salary (which has subsequently been increased to the amount described above under “Base Salary”), subject to adjustment by the Board or our Compensation Committee, and an initial target annual bonus equal to 50% of her annual base salary, with the actual amount of such bonus to be determined by the Board or our Compensation Committee in accordance with the terms of the Company’s annual cash incentive program then in effect. In addition, Dr. Buell is bound by certain restrictive covenant obligations, including covenants relating to confidentiality and assignment of inventions, as well as covenants not to compete or solicit certain of our service providers, customers, and suppliers during her employment and for twelve (12) months after her termination of employment (excluding, with

<div align='center'>16</div>

respect to the non-competition covenants, any termination of employment due to layoff or in the absence of reasonable grounds for termination as specified in the employment agreement), or, with respect to the non-solicitation covenants, for the greater of twelve (12) months after her termination of employment or the period during which Dr. Buell is receiving severance payments under the employment agreement.

Dr. van Dijk.Prior to his resignation in November 2024, one of our subsidiaries was party to an employment agreement with Dr. van Dijk that provided for his entitlement to an annual base salary (which was subsequently increased to the amount described above under “Base Salary”) and eligibility to earn an annual cash bonus, with a target of